Faron Pharmaceuticals Oy
FARN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £219,230 | £233,541 | £187,977 | £161,933 |
| - Cash | £9,503 | £6,875 | £6,990 | £6,853 |
| + Debt | £12,113 | £13,111 | £13,269 | £3,547 |
| Enterprise Value | £221,840 | £239,777 | £194,256 | £158,627 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | -£18 | -£28,371 | -£27,057 | -£20,973 |
| % Margin | – | – | – | – |
| Net Income | -£26 | -£30,944 | -£28,730 | -£21,194 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.34 | -0.38 | -0.29 |
| % Growth | 99.9% | 10.5% | -31% | – |
| Operating Cash Flow | -£22,971 | -£23,806 | -£22,993 | -£22,218 |
| Capital Expenditures | -£226 | -£123 | -£385 | -£474 |
| Free Cash Flow | -£23,197 | -£23,929 | -£23,378 | -£22,692 |